Sonnet Biotherapeutics Holdings Inc (SONN) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sonnet Biotherapeutics Holdings Inc   (NASDAQ: SONN)


Sonnet Biotherapeutics Holdings Inc 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Sonnet Biotherapeutics Holdings Inc 's ROA in the fourth quarter of 2025?
Sonnet Biotherapeutics Holdings Inc recorded a cumulative net loss of $-16 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -271.99%.

However, within the Healthcare sector 918 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2025 quarter, so far to 4678, from total ROA ranking in the third quarter of 2025 at 4809.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter		 (Mar 31 2025)
II. Quarter		 (Dec 31 2024)
I. Quarter		 (Sep 30 2024)
IV. Quarter
Y / Y Total Assets Change 437.14 % -64.54 % -35.08 % -48.96 % -48.96 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -16 -14 -13 -9 -7
Return On Assets (TTM) -271.99 % -474.25 % -350.2 % -218.67 % -149.44 %
SONN's Total Ranking # 4678 # 4809 # 4847 # 5494 # 4765
Total Assets (TTM) in million 15 2 4 3 3
Seq. Total Assets Change 624.2 % -46.43 % 38.44 % 0 % -52.2 %
Seq. Net Income Change - - - - -

SONN's 5 Years Annual ROA >> Back to SONN Management Effectiveness >> Compare SONN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 448
Sector # 919
Overall # 4621

Return On Assets Statistics
High Average Low
-79.93 %
-242.79 %
-474.25 %
(Jun 30 2021)   (Jun 30 2025)





Financial Statements
Sonnet Biotherapeutics Holdings Inc 's Assets $ 15 million SONN's Balance sheet
Sonnet Biotherapeutics Holdings Inc 's Income $ -6 million Quarterly SONN's Income Statement
SONN's Income by Division See SONN's Income by Division



Annual Return On Assets (Sep 30 2025)
FY 2025		 (Sep 30 2024)
FY 2024		 (Sep 30 2023)
FY 2023		 (Sep 30 2022)
FY 2022		 (Sep 30 2021)
FY 2021
Y / Y Total Assets Change 437.14 % -48.96 % -6.87 % -79.89 % 426.71 %
Total Assets in million 15 3 5 6 29
Y / Y Net Income Change - - - - -
Net Income in million -16 -7 -19 -30 -25
Annual Return On Assets -107.57 % -268.39 % -346.86 % -509.81 % -86.17 %

SONN's 5 Years Annual ROA >> Back to SONN Management Effectiveness >> Compare SONN ROA to its Competitors



More Return On Assets Ratios
SONN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SONN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SONN's Competitors
Subscribers only: Roa for Sonnet Biotherapeutics Holdings Inc 's Suppliers
Subscribers only: Return On Assets for SONN's Customers

You may also want to know
SONN's Roi SONN's Inventory Turnover Ratio SONN's Growth Rates SONN's Dividend Comparisons
SONN's Profitability Ratios SONN's Asset Turnover Ratio SONN's Dividend Growth
SONN's Roe SONN's Valuation Ratios SONN's Financial Strength Ratios SONN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2025, within Healthcare Sector ROA

Date modified: 2026-08-29T07:16:11+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.